Macquarie Group Portfolio holdings
AUM
$81.5B
1-Year Return
21.2%
This Quarter Return
+10.74%
1 Year Return
+21.2%
3 Year Return
+85%
5 Year Return
+166.7%
10 Year Return
+339.95%
AUM
$84.7B
AUM Growth
+$3.15B
(+3.9%)
Cap. Flow
-$3.42B
Cap. Flow
% of AUM
-4.04%
Top 10 Holdings %
Top 10 Hldgs %
10.93%
Holding
2,551
New
35
Increased
617
Reduced
853
Closed
517
Top Buys
| 1 |
L3Harris
LHX
|
$119M |
| 2 |
Danaher
DHR
|
$116M |
| 3 |
Zebra Technologies
ZBRA
|
$111M |
| 4 |
West Pharmaceutical
WST
|
$87.2M |
| 5 |
Assurant
AIZ
|
$87M |
Top Sells
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$196M |
| 2 |
Microsoft
MSFT
|
$189M |
| 3 |
Merck
MRK
|
$147M |
| 4 |
Mastercard
MA
|
$130M |
| 5 |
ABMD
Abiomed Inc
ABMD
|
$124M |
Sector Composition
| 1 | Technology | 21.39% |
| 2 | Healthcare | 15.17% |
| 3 | Financials | 13.51% |
| 4 | Industrials | 10.72% |
| 5 | Consumer Discretionary | 9.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
NMI Holdings
NMIH
$3.09B
| $78.4M | 0.09% |
3,749,576
+86,377
| +2% | +$1.81M |
|
302
Adient
ADNT
$1.98B
| $78.2M | 0.09% |
2,253,358
+39,559
| +2% | +$1.37M |
|
303
AT&T
T
$208B
| $78.1M | 0.09% |
4,241,274
-204,678
| -5% | -$3.77M |
|
304
Hanover Insurance
THG
$6.35B
| $77.6M | 0.09% |
573,921
-270,162
| -32% | -$36.5M |
|
305
Generac Holdings
GNRC
$10.8B
| $77.4M | 0.09% |
769,182
+278,347
| +57% | +$28M |
|
306
Group 1 Automotive
GPI
$6.22B
| $77.4M | 0.09% |
428,970
-17,956
| -4% | -$3.24M |
|
307
Kadant
KAI
$3.85B
| $77.2M | 0.09% |
434,593
+9,372
| +2% | +$1.66M |
|
308
Cirrus Logic
CRUS
$5.98B
| $76.6M | 0.09% |
1,028,526
+4,662
| +0.5% | +$347K |
|
309
Diodes
DIOD
$2.45B
| $76.4M | 0.09% |
1,003,256
+18,670
| +2% | +$1.42M |
|
310
Genpact
G
$7.71B
| $76.3M | 0.09% |
1,647,670
+117,972
| +8% | +$5.46M |
|
311
Baidu
BIDU
$37.3B
| $76.3M | 0.09% |
666,715
-57,233
| -8% | -$6.55M |
|
312
Apellis Pharmaceuticals
APLS
$3.46B
| $75.6M | 0.09% |
1,461,642
+40,107
| +3% | +$2.07M |
|
313
MYR Group
MYRG
$2.79B
| $75.1M | 0.09% |
815,991
-202,353
| -20% | -$18.6M |
|
|
RPT
314
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $75.1M | 0.09% |
7,476,868
-164,275
| -2% | -$1.65M |
|
315
McKesson
MCK
$85.9B
| $74.9M | 0.09% |
199,668
-15,552
| -7% | -$5.83M |
|
316
Martin Marietta Materials
MLM
$37.6B
| $74.9M | 0.09% |
221,484
+184,388
| +497% | +$62.3M |
|
317
Travere Therapeutics
TVTX
$1.89B
| $74.8M | 0.09% |
3,556,112
+245,856
| +7% | +$5.17M |
|
318
Quanta Services
PWR
$56.3B
| $74.6M | 0.09% |
523,397
-37,470
| -7% | -$5.34M |
|
319
EOG Resources
EOG
$63.8B
| $74.1M | 0.09% |
572,479
+60,392
| +12% | +$7.82M |
|
320
Hamilton Lane
HLNE
$6.45B
| $74.1M | 0.09% |
1,160,680
+174,310
| +18% | +$11.1M |
|
321
Procter & Gamble
PG
$372B
| $74M | 0.09% |
488,221
-11,333
| -2% | -$1.72M |
|
322
Amgen
AMGN
$150B
| $73.8M | 0.09% |
280,962
-10,703
| -4% | -$2.81M |
|
323
AbbVie
ABBV
$368B
| $73.8M | 0.09% |
456,573
+18,881
| +4% | +$3.05M |
|
324
Columbia Sportswear
COLM
$3.07B
| $73.7M | 0.09% |
842,077
-36,571
| -4% | -$3.2M |
|
325
OGE Energy
OGE
$8.81B
| $73.4M | 0.09% |
1,855,015
-272,014
| -13% | -$10.8M |
|